Table 2b.
Clinical and pathological characteristics of the study cohort (N = 421)
| Categorical | n | % |
|---|---|---|
| FAM | ||
| no | 357 | 84.8 |
| yes | 64 | 15.2 |
| SMK | ||
| no | 218 | 51.8 |
| yes | 203 | 48.2 |
| DRE | ||
| normal | 338 | 80.3 |
| anormal | 83 | 19.7 |
| PCa | ||
| no | 229 | 54.4 |
| yes | 192 | 45.6 |
| CII | ||
| no | 331 | 78.6 |
| yes | 90 | 21.4 |
| GA | ||
| no | 391 | 92.9 |
| yes | 30 | 7.1 |
| ASAP | ||
| no | 367 | 87.2 |
| yes | 54 | 12.8 |
| PIN | ||
| no | 403 | 95.7 |
| yes | 18 | 4.3 |
| bGS | ||
| 6 | 107 | 55.7 |
| 7 | 69 | 35.9 |
| 8 | 10 | 5.2 |
| 9 | 6 | 3.1 |
| bGP1 | ||
| 3 | 157 | 81.8 |
| 4 | 34 | 17.7 |
| 5 | 1 | 0.5 |
| bGP2 | ||
| 3 | 128 | 66.7 |
| 4 | 57 | 29.7 |
| 5 | 7 | 3.6 |
| N+ | ||
| 1–2 | 77 | 40.1 |
| > 2 | 115 | 59.9 |
FAM = Family history of PCA; SMK = smoking; GA = glandular atrophy; bGS = biopsy Gleason score; bGP = biopsy Gleason pattern.